Control of local and regional subclinical disease by radiation therapy
- PMID: 944088
Control of local and regional subclinical disease by radiation therapy
Abstract
An irradiation dose of 5000 rads in 5 weeks appears to be highly efficient for eradication of subclinical disease in the oropharynx or nasopharnyx. Irradiation alone in the range of 4500 to 5000 rads, five treatments per week, 4 1/2 to 5 weeks, appears to be greater than 90% efficient for eradicating subclinical disease for both squamous-cell carcinoma and adenocarcinoma in regional lymph nodes. The site of origin of the primary squamous-cell carcinoma or adenocarcinoma seems to be independent of the response in the regional lymph nodes. It is unknown whether concomitant elective chemotherapy will modify the dose for control required for subclinical disease in squamous-cell carcinoma or adenocarcinoma.
Similar articles
-
Preoperative radiation.Surg Gynecol Obstet. 1968 May;126(5):1091-105. Surg Gynecol Obstet. 1968. PMID: 4297395 Review. No abstract available.
-
The interplay of radiocurability and tolerance in the irradiation of human cancers.J Radiol Electrol Med Nucl. 1975 May;56(5):383-400. J Radiol Electrol Med Nucl. 1975. PMID: 1177184 No abstract available.
-
Clinical dose-response curve of subclinical aggregates of epithelial cells.J Radiol Electrol Med Nucl. 1972 Mar;53(3):201-6. J Radiol Electrol Med Nucl. 1972. PMID: 5051022 No abstract available.
-
Present status of low-LET radiation in the management of cancers: a challenge to high-LET radiation.Int J Radiat Oncol Biol Phys. 1977;3:7-19. doi: 10.1016/0360-3016(77)90221-8. Int J Radiat Oncol Biol Phys. 1977. PMID: 96080 No abstract available.
-
[Results of radiotherapy of malignant neoplasms with fractionated doses].Med Radiol (Mosk). 1973 Jan;18(1):73-81. Med Radiol (Mosk). 1973. PMID: 4200135 Review. Russian. No abstract available.